ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013